17-alpha-hydroxyprogesterone has been researched along with Androblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asirvatham, AR; Balachandran, K; Kamani, S; Sampathkumar, G | 1 |
| Bennet, A; Caron, P; Donadille, F; Escourrou, G; Hamdi, S; Leguevaque, P; Motton, S; Persechini, ML; Vierasu, B | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Androblastoma
| Article | Year |
|---|---|
Sertoli-Leydig cell tumour in a patient with non-classic congenital adrenal hyperplasia: an uncommon duo.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Female; Humans; Incidental Findings; Salpingo-oophorectomy; Sertoli-Leydig Cell Tumor; Virilism | 2019 |
Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Amenorrhea; Androstenedione; Brenner Tumor; Clitoris; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Ovarian Neoplasms; Ovariectomy; Sertoli-Leydig Cell Tumor; Testosterone; Treatment Outcome; Virilism | 2011 |